** Shares of Israeli digital intelligence co Cellebrite DI CLBT.O jump almost 19% to $19.05 premarket

** Q3 revenue up 18% YoY, beats analyst estimates - data compiled by LSEG

** Raises lower end of FY25 revenue outlook to $470-475 mln from $465-475 mln range

** Cites expansion with U.S. Federal clients, 21% subscription revenue growth driven by state, local and Latin America demand

** Q3 profit misses estimates

** At least two brokerages hike PTs post-results; all 8 analysts rate stock "buy" or higher with $24 median PT - data compiled by LSEG

** Stock had fallen 27.5% YTD through last close

(Reporting by Avinash P in Bengaluru)

((Avinash.P@Thomsonreuters.com))